Press Releases
WILMINGTON, Del., Nov. 13, 2023 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.385 cents per share on the company's common stock. The dividend is payable on December 15, 2023, to stockholders of record at the close of business on
Sales of $518 million, down eighteen percent from the prior-year quarter Net loss (including discontinued operations) of $4 million, or $0.07 per diluted share Loss from continuing operations of $8 million, or $0.15 per diluted share Adjusted income from continuing operations excluding intangibles
Bangkok, Thailand, November 7, 2023 – As we approach the end of 2023, there is a growing desire among individuals to embrace scientific, holistic methods for well-being on mind-body exhausted days. Ashland innovatively integrates wellness into the AI-enabled beauty solutions and ushers consumers
Company will share materials expertise including new Klucel Fusion ™ hpc Wilmington, Del., Nov. 6, 2023 - Ashland will join The University of Texas at Austin - College of Pharmacy and other pharmaceutical industry leaders of advanced extrusion technology at the Life Science Twin Screw Extrusion
Results in the fourth quarter reflect a customer-demand environment that was generally consistent with expectations Fourth-quarter and full-year earnings are below expectations driven primarily by additional inventory-control actions Initiation of portfolio-optimization actions to further
Wilmington, Del., October 25, 2023 - Ashland will highlight GPM ™ vitamins and minerals produced from a nutrient-dense broth that is cultured, converted, and bio-transformed by microorganisms (yeast and/or probiotics) during the SupplySide West exhibition in Las Vegas, October 23-27, 2023.
Innovation helps eliminate solvents, reduces energy consumption, enhances throughput, reduces operating cost and shortens scaleup development time Wilmington, Del., Oct. 23, 2023 - Ashland is introducing Klucel Fusion ™ hydroxypropyl cellulose (hpc), a new polymer expressly designed to optimize
Wilmington, Del., Oct. 16, 2023 – Under Ashland’s new bioresorbable technology platform, the company is introducing Viatel™ Ultrapure high-purity bioresorbable polymers . This line extension delivers improved stability for sensitive drug compounds and longer, more consistent drug release profiles
WILMINGTON, Del., October 14, 2023 – Ashland is presenting new Rad-Sure™ blood irradiation indicators at the 2023 AABB Annual Meeting, Nashville, TN, October 14 to 17, 2023. Rad- Sure™ blood irradiation indicators are used to verify that the blood has been irradiated properly for transfusion
Wilmington, Del., October 12, 2023 - Under Ashland’s new transformed vegetable oils technology platform, the company has launched Gantrez ™ soja delivery system for toothpaste and mouthwash. Gantrez ™ soja is a nature-derived, biodegradable active delivery system for oral care that retains